Home LiteratureArticle Details
PMID: 7760641 Published · ppublish English Case Reports Comment Letter

Tumour necrosis factor inhibition by oxpentifylline and intestinal inflammation in Crohn's disease.

Lancet (London, England) ·Vol. 345 ·No. 8962 ·1995-06-03 ·Pages 1445

Bauditz J, Rückert Y, Raedler A, Nikolaus S, Lochs H, Schreiber S

Abstract

暂无摘要

MeSH Terms
Adult Colitis/drug therapy Crohn Disease/drug therapy Female Humans Male Pentoxifylline/pharmacology,therapeutic use Tumor Necrosis Factor-alpha/antagonists & inhibitors
Chemicals
Tumor Necrosis Factor-alpha Pentoxifylline
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Bauditz J
Rückert Y
Raedler A
Nikolaus S
Lochs H
Schreiber S
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
DOI
10.1016/s0140-6736(95)92635-6
Published
1995-06-03
Pages
1445
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Corrections
CommentOn
PMID: 8101267
External Links
PubMed source DOI: 10.1016/s0140-6736(95)92635-6 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2